BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6056544)

  • 1. Tacrine inhibition of serum cholinesterase and prolonged succinylcholine action.
    Benveniste D; Hemmingsen L; Juul P
    Acta Anaesthesiol Scand; 1967; 11(3):297-309. PubMed ID: 6056544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of neuroleptanalgesia preparations and succinylcholine derivatives on human blood serum cholinesterase].
    Fridliand MI
    Anesteziol Reanimatol; 1980; (1):17-9. PubMed ID: 7377608
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancuronium and the fasciculations of succinylcholine.
    Bennett EJ; Montgomery SJ; Dalal FY; Raj PP
    Anesth Analg; 1973; 52(6):892-6. PubMed ID: 4796562
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of the kallikrein-trypsin inactivator Trasylol on the serum cholinesterase.
    Chasapakis G; Augustaki O; Kekis N; Philippou P; Moraitis H; Floras A; Makkous A
    Br J Anaesth; 1968 Jun; 40(6):456-8. PubMed ID: 5301414
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atypical cholinesterase variants and neuroleptoanalgesia].
    Mkheidze MO; Fridliand MI
    Anesteziol Reanimatol; 1977; (2):51-3. PubMed ID: 879541
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of aprotinin (Trasylol) on the action of suxamethonium.
    Chasapakis G
    Br J Anaesth; 1972 Feb; 44(2):229. PubMed ID: 4536961
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrine does not alter the potency of succinylcholine in the rat.
    Ibebunjo C; Eshelby D; Donati F; Fox GS; Tchervenkov JI
    Can J Anaesth; 1997 Sep; 44(9):1021-6. PubMed ID: 9305568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinesterases and subsequent duration of block of suxamethonium.
    Graham SG
    Br J Anaesth; 1997 Apr; 78(4):480-1. PubMed ID: 9135338
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of trasylol on the action of muscle relaxants and the serum cholinesterase activity.
    Iwatsuki K; Hashimoto Y; Shima T
    Tohoku J Exp Med; 1971 Jun; 104(2):105-9. PubMed ID: 5315018
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of aprotinin (Trasylol) on the action of suxamethonium.
    Doenicke A; Gesing H; Krumey I; Schmidinger S
    Br J Anaesth; 1970 Nov; 42(11):948-60. PubMed ID: 5312619
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental studies of the breakdown of Epontol: determination of propanidid in human serum.
    Doenicke A; Krumey I; Kugler J; Klempa J
    Br J Anaesth; 1968 Jun; 40(6):415-29. PubMed ID: 4871804
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of serum cholinesterase variants by succinyldicholine inhibition.
    King J; Griffin D
    Br J Anaesth; 1973 May; 45(5):450-4. PubMed ID: 4715591
    [No Abstract]   [Full Text] [Related]  

  • 14. Sexamethonium and serum cholinesterase. Comparative studies in vitro and in vivo on the catabolism of suxamethonium.
    Doenicke A; Schmidinger S; Krumey I
    Br J Anaesth; 1968 Nov; 40(11):834-44. PubMed ID: 5704352
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between suxamethonium apnoea, serum cholinesterase activity and inhibitor numbers.
    King J; Griffin D
    Br J Anaesth; 1974 Dec; 46(12):908-11. PubMed ID: 4621224
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
    Scaf AH; van den Akker J; Westenberg HG
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between Trasylol and depolarizing curares].
    Baiocchi P; Tonietto G; Vidal M; Grube A
    Acta Anaesthesiol; 1969; 20(5):867-79. PubMed ID: 5311870
    [No Abstract]   [Full Text] [Related]  

  • 18. Scope and limitations of propionylthiocholinesterase in the characterisation of cholinesterase variants.
    Price EM; Brown SS
    Clin Biochem; 1975 Dec; 8(6):384-90. PubMed ID: 1204213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientific Review No. 5. Assay of cholinesterase in clinical chemistry.
    Silk E; King J; Whittaker M
    Ann Clin Biochem; 1979 Mar; 16(2):57-75. PubMed ID: 37798
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative importance of the enzymic hydrolysis of suxamethonium in plasma and tissues: studies in cats.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1971 Oct; 43(2):341-8. PubMed ID: 4333803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.